Acellular Pertussis Completed Phase 3 Trials for Haemophilus influenzae type b strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen (DB10990)

IndicationStatusPhase
DBCOND0031302 (Acellular Pertussis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02096263Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy InfantsPrevention
NCT00412854Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.Prevention
NCT00696423Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in ChildrenPrevention
NCT01309646Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib VaccinePrevention